Aaron Wealth Advisors LLC Sells 1,377 Shares of Intuitive Surgical, Inc. $ISRG

Aaron Wealth Advisors LLC cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 21.9% in the 1st quarter, HoldingsChannel.com reports. The firm owned 4,903 shares of the medical equipment provider’s stock after selling 1,377 shares during the quarter. Aaron Wealth Advisors LLC’s holdings in Intuitive Surgical were worth $2,261,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the stock. Brighton Jones LLC raised its position in Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after buying an additional 731 shares during the last quarter. Sivia Capital Partners LLC lifted its stake in Intuitive Surgical by 3.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after acquiring an additional 34 shares in the last quarter. Schnieders Capital Management LLC. boosted its holdings in Intuitive Surgical by 38.0% during the 2nd quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock worth $529,000 after acquiring an additional 268 shares during the last quarter. Osterweis Capital Management Inc. bought a new stake in shares of Intuitive Surgical in the 2nd quarter worth $200,000. Finally, Main Street Financial Solutions LLC grew its stake in shares of Intuitive Surgical by 92.4% in the 2nd quarter. Main Street Financial Solutions LLC now owns 2,929 shares of the medical equipment provider’s stock worth $1,592,000 after acquiring an additional 1,407 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Goldman Sachs and other industry analysts defended Intuitive Surgical’s core business, saying concerns over new rules on instrument reuse are unlikely to materially disrupt the company’s revenue model. Intuitive Surgical (ISRG) Faces Reuse Questions As Goldman Sachs Backs Fundamentals
• Positive Sentiment: Coverage comparing ISRG with Zimmer Biomet said Intuitive Surgical stands out on stronger revenue growth, rising procedure demand, and expanding AI-driven innovation, which supports a better upside case in 2026. ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?
• Positive Sentiment: Intuitive Surgical received acknowledgement for its da Vinci Single Port robotic platform, reinforcing the company’s leadership in robotic surgery technology. Intuitive Surgical (ISRG) Garners Acknowledgement for Da Vinci Single Port Robotic Platform
• Neutral Sentiment: Short-interest data showed essentially no short interest in ISRG, so there is little evidence of bearish positioning from that metric alone.
• Negative Sentiment: Deutsche Bank reiterated a Sell rating and cut its price target to $366 from $440, adding to the analyst pressure weighing on shares. Deutsche Bank Maintains a Sell Rating on Intuitive Surgical (ISRG), Here’s Why
• Negative Sentiment: Broader commentary noted ISRG has been one of the market’s most punished large-cap healthcare names this year, reflecting investor concern despite ongoing revenue growth. Goldman Sachs Intuitive Surgical call goes against the grain

Insiders Place Their Bets

In other news, Director Amy L. Ladd sold 119 shares of the stock in a transaction on Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total transaction of $55,156.50. Following the completion of the transaction, the director owned 120 shares in the company, valued at approximately $55,620. This represents a 49.79% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of Intuitive Surgical stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the sale, the senior vice president directly owned 6,463 shares of the company’s stock, valued at approximately $2,718,014.65. This trade represents a 46.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 7,169 shares of company stock valued at $3,059,135 over the last ninety days. 0.60% of the stock is currently owned by insiders.

Intuitive Surgical Stock Down 0.5%

ISRG opened at $399.69 on Friday. The stock has a market cap of $141.55 billion, a price-to-earnings ratio of 48.45, a PEG ratio of 3.27 and a beta of 1.46. Intuitive Surgical, Inc. has a twelve month low of $396.68 and a twelve month high of $603.88. The company’s 50-day moving average price is $433.94 and its two-hundred day moving average price is $485.17.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.08 by $0.42. The company had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. Intuitive Surgical’s quarterly revenue was up 23.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.81 EPS. As a group, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on ISRG. Citigroup raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price target on the stock in a research report on Wednesday, March 11th. Leerink Partners reduced their price objective on shares of Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating for the company in a research report on Wednesday, April 22nd. TD Cowen decreased their price objective on shares of Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. The Goldman Sachs Group set a $558.00 target price on shares of Intuitive Surgical in a research report on Wednesday, May 27th. Finally, Barclays set a $651.00 target price on Intuitive Surgical and gave the stock an “overweight” rating in a research note on Thursday, April 23rd. Nineteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $573.42.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.